About Marienthali Kliinik
"Vaimse tervise kliinik. Tegevusluba L04146"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
H. Lundbeck A/S
6
Janssen Research & Development, LLC
1
Clinical Trials at Marienthali Kliinik
During the past decade, Marienthali Kliinik conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)
2016-05-18
2022-01-21
Completed
683
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
2016-08-17
2022-04-19
Terminated
662
Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia
2018-12-27
2020-09-03
Terminated
168
Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
2019-12-27
2021-03-09
Completed
100
Vortioxetine in Patients With Depression and Early Dementia
2020-02-28
2022-07-20
Completed
82
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression
2020-06-18
2022-02-04
Completed
605
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
2020-09-15
2023-11-24
Recruiting
720
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Marienthali Kliinik"
#1 collaborator was "ICON plc" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Marienthali Kliinik
According to Clinical.Site data, the most researched conditions in "Marienthali Kliinik" are
"Depressive Disorder, Major" (3 trials), "Major Depressive Disorder" (2 trials), "Anxiety Disorders" (1 trials), "Dementia" (1 trials) and "MDD" (1 trials). Many other conditions were trialed in "Marienthali Kliinik" in a lesser frequency.
Clinical Trials Intervention Types at Marienthali Kliinik
Most popular intervention types in "Marienthali Kliinik" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Vortioxetine" (4 trials), "Placebo" (2 trials), "Desvenlafaxine" (1 trials), "Fluoxetine 20mg/day" (1 trials) and "Lu AF11167 (1-2 mg/day)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Marienthali Kliinik
The vast majority of trials in "Marienthali Kliinik" are
7 trials for "All" genders.
Clinical Trials Status at Marienthali Kliinik
Currently, there are NaN active trials in "Marienthali Kliinik".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Marienthali Kliinik,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Marienthali Kliinik, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".